Search Results - "Gutierrez Nicolás, Fernando"

Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease by Cantarelli, Lorenzo, Carrillo Palau, Marta, Hernandez Guerra, Manuel, Nazco Casariego, Gloria Julia, Gutierrez Nicolás, Fernando

“…Monitoring plasma levels of Infliximab plays an important role in optimising treatment in patients with inflammatory bowel disease (IBD). The aim of the…”
Get more information

Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study by Miarons, Marta, Manzaneque Gordón, Alba, Riera, Pau, Gutiérrez Nicolás, Fernando

“…Abstract Introduction Identifying polymorphisms in the dihydropyrimidine dehydrogenase (DPYD) gene is gaining importance to be able to predict…”
Get full text

Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer by Padrón, Ivette Mourani, García, Jonathan González, Díaz, Ruth Ramos, Lenza, Isaac Ceballos, Nicolás, Fernando Gutiérrez

“…Introduction Trastuzumab is a monoclonal antibody which could induce the activation of a humoral immune response generating anti-drug antibodies (ADAs). Such…”
Get full text

Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer by Peña-Cabia, Silvia, Royuela Vicente, Ana, Ramos Díaz, Ruth, Gutiérrez Nicolás, Fernando, Peñalver Vera, Ángela, Siso García, Isabel, Hitt Sabag, Ricardo, García Lacalle, Concepción, Peña-Cabia, Ana, Iglesias-Peinado, Irene, García Díaz, Benito, López-Martín, Ana

“…Limited literature is available for bevacizumab exposure-response relationship and there is not a concentration threshold associated with an optimal disease…”
Get full text

Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia by Del Rosario García, Betel, Viña Romero, María Micaela, González Rosa, Virginia, Alarcón Payer, Carolina, Oliva Oliva, Leonor, Merino Alonso, Francisco Javier, Nazco Casariego, Gloria Julia, Gutiérrez Nicolás, Fernando

“…Objective Tyrosine kinase inhibitors (TKIs) have successfully changed the natural course of chronic myeloid leukaemia (CML). Although they are highly effective…”
Get full text

Imatinib plasma levels in patients with gastrointestinal stromal tumour under routine clinical practice conditions by Del Rosario García, Betel, Morales Barrios, José Alberto, Jurado, Josefina Cruz, Díaz, Ruth Ramos, Viña Romero, María Micaela, Padrón, Ivette Mourani, Nazco Casariego, Gloria Julia, Nicolás, Fernando Gutiérrez

“…Objectives Imatinib is the first therapeutic option for the treatment of unresectable or metastatic gastrointestinal stromal tumours. Previous studies have…”
Get full text

Imatinib plasma levels in patients with chronic myeloid leukaemia under routine clinical practice conditions by Del Rosario García, Betel, González García, Iris, Viña Romero, María Micaela, González García, Jonathan, Ramos Díaz, Ruth, Mourani Padrón, Ivette, Lakhwani Lakhwani, Sunil, Nazco Casariego, Gloria Julia, Gutiérrez Nicolás, Fernando

“…Introduction The addition of imatinib to the therapeutic arsenal for chronic myeloid leukaemia (CML) has changed the natural course of the disease, in such a…”
Get full text

Pharmacist-led medication reconciliation to reduce discrepancies in transitions of care in Spain by Allende Bandrés, Maria Ángeles, Arenere Mendoza, Mercedes, Gutiérrez Nicolás, Fernando, Calleja Hernández, Miguel Ángel, Ruiz La Iglesia, Fernando

“…Background Medication errors are one of the main causes of morbidity amongst hospital inpatients. More than half of medication errors occur at ‘interfaces of…”
Get full text

Ten-minute administration of bevacizumab by García Gil, Sara, Gutiérrez Nicolás, Fernando, González De La Fuente, Guillermo A, Nazco Casariego, Gloria J, Viña Romero, M Micaela, Batista López, J Norberto

“…ObjectiveTo describe our experience of administering bevacizumab doses at 0.5 mg/kg/min. The main objective of the study was to evaluate the safety of this…”
Get full text

Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell lung cancer in Spain by García, Jonathan González, Nicolás, Fernando Gutiérrez, Casariego, Gloria Julia Nazco, Nazco, Cristina Valcárcel, López, José Norberto Batista, Rodríguez, Juana Oramas

“…Lung cancer is the third most frequent neoplastic tumour in Spain, with around 27 000 new cases diagnosed per year; 80-95% of these are non-small-cell cancer…”
Get full text

Reducing the degree of colonisation of venous access catheters by continuous passive disinfection by Gutiérrez Nicolás, Fernando, Nazco Casariego, Gloria Julia, Viña Romero, María Micaela, González García, Jonathan, Ramos Diaz, Ruth, Perez Perez, Jose Antonio

“…IntroductionThe advent of Luer-type needleless venous access catheters has been accompanied by a growing number of catheter-related bloodstream infections. Our…”
Get full text

Efficacy and Safety of Erenumab, Galcanezumab, and Fremanezumab in the Treatment of Drug-Resistant Chronic Migraine: Experience in Real Clinical Practice by Cantarelli, Lorenzo, Pestana Grafiña, Diana, Gonzalez Perez, Amanda, García Gil, Sara, Gutiérrez Nicolás, Fernando, Ramos Santana, Emma, Navarro Dávila, Marco Antonio, Otazo Pérez, Sheila María, Calzado Gómez, Gloria, Perez Reyes, Sergio, Nazco Casariego, Gloria Julia

“…Background: Due to the recent introduction of new biologic drugs for chronic migraine, a global evaluation in real clinical practice is necessary. Objective:…”
Get full text

Efficacy and safety of high doses of irinotecan in patients with metastatic colorectal cancer treated with the FOLFIRI regimen based on the UGT1A1 genotype: A systematic review by Miarons, Marta, Riera, Pau, García-Gil, Sara, Gutiérrez-Nicolás, Fernando

“…The purpose of this systematic review is to analyze the published data on the efficacy and safety of doses higher than 180 mg/m2 of irinotecan recommended in…”
Get full text

Effect of Concomitant Use of Proton Pump Inhibitors on Immunotherapy Clinical Response in Advanced Cancer Patients: Real-Life Setting by Cantarelli, Lorenzo, Gutiérrez Nicolás, Fernando, García Gil, Sara, Morales Barrios, Jose A., Oramas Rodriguez, Juana, Nazco Casariego, Gloria J.

“…The alteration of the gut microbiota mediated by proton pump inhibitor (PPI) drugs could be involved in the clinical response associated with immunotherapy…”
Get full text

Activity of Erwinia-asparaginase after anaphylactic reaction to Peg-asparaginase by Viña Romero, Maria Micaela, García Gil, Sara, Nazco Casariego, Gloria Julia, Merino Alonso, Javier, Gutiérrez Nicolás, Fernando

Get full text

Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients by González García, Jonathan, Gutiérrez Nicolás, Fernando, Ramos Díaz, Ruth, Nazco Casariego, Gloria Julia, Viña Romero, María Micaela, Llabres Martinez, Matías, Llanos Muñoz, Marta, Batista López, José Norberto, Jiménez Sosa, Alejandro, Ceballos Lenza, Isaac, Cruz Jurado, Josefina

“…Background: Subcutaneous trastuzumab (T-SC) administration does not allow the historical target concentration of 20 µg/mL for efficacy to be reached, from the…”
Get full text

Influence of Anthropometric Characteristics in Patients With Her2-Positive Breast Cancer on Initial Plasma Concentrations of Trastuzumab by González García, Jonathan, Gutiérrez Nicolás, Fernando, Nazco Casariego, Gloria Julia, Batista López, José Norberto, Ceballos Lenza, Isaac, Ramos Díaz, Ruth, Llabrés Martínez, Matías

“…Background: Plasma concentrations of trastuzumab <20 µg/mL in patients with gastric cancer are associated with reduced progression-free and overall survival…”
Get full text

A slowdown of hepatitis C diagnosis in high-prevalence groups and with decentralized diagnostic strategies during the COVID-19 pandemic by Morales-Arráez, Dalia, Benítez-Zafra, Federica, Díaz-Flores, Felicitas, Medina-Alonso, María Jesús, Santiago, Luz Goretti, Pérez-Pérez, Víctor, Gutiérrez-Nicolás, Fernando, Hernández-Guerra, Manuel

“…the COVID-19 pandemic has had a major impact on hepatitis C virus (HCV) diagnosis by hindering the path to elimination. Albeit, in an uneven manner, depending…”
Get full text

Adherence to subcutaneous biologic treatment for inflammatory bowel disease by Ramos, Laura, Ramos-Rodríguez, Javier, Barreda, Raquel De La, Gutiérrez-Nicolás, Fernando, Carrillo-Palau, Marta, Alonso-Abreu, Inmaculada, Nazco-Casariego, Julia, Quintero, Enrique

“…Nonadherence to medication is common in patients with inflammatory bowel disease (IBD) and can result in disease complications, therapy escalation, and the…”
Get more information

Extended enzymatic stability of reconstituted lyophilized PEG-asparaginase in vials by Viña-Romero, María M, Ramos Díaz, Ruth, González García, Jónathan, Nazco-Casariego, Gloria, Díaz-Vera, Jésica, Gutiérrez-Nicolás, Fernando

“…Asparaginase (ASNase) use as a tumour-inhibitor drug has changed completely the natural course of paediatric acute lymphoblastic leukaemia (ALL) in such a way…”
Get full text